Biotech

All Articles

Vaderis' unusual blood vessel problem drug reduces nosebleeds

.Vaderis Therapeutics' objective to create the first drug intended particularly at a certain rare bl...

Navigator raises $100M to create new autoimmune pipeline

.Sat nav Medicines has outfitted itself with $100 thousand in collection A funds as the younger biot...

Duality looks for money for ADC tests as IPO surge infects Asia

.China's Duality Biotherapeutics has filed (PDF) paperwork for a Hong Kong IPO, looking for an undis...

YolTech offers China liberties to gene modifying treatment for $29M

.4 months after Mandarin genetics editing and enhancing company YolTech Therapies took its cholester...

Addex stock climbs after Indivior offers up to $300M for compound

.Indivior is actually grabbing a small molecule allosteric modulator designed to alleviate compound ...

Molecular Allies fine-tunes AML trial over 'suboptimal visibility'

.Molecular Partners has actually pinpointed "suboptimal exposure" to its own tetra-specific T-cell e...

Despite combined market, a venture capital resurgence can be coming in Europe: PitchBook

.While the biotech investment scene in Europe has actually decreased relatively adhering to a COVID-...

8 months after a $213M fundraise, gene publisher Tome helps make decreases

.After bring up $213 million in 2023-- some of the year's most extensive exclusive biotech shots-- T...

BioMarin creates exec staff with biotech vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, firings as w...

Biopharma Q2 VC hit highest degree given that '22, while M&ampA decreased

.Financial backing financing right into biopharma rose to $9.2 billion around 215 handle the second ...